Experience with Pediatric Chronic Immune Thrombocytopenia over 30 Years in the Era before Eltrombopag
Background: There is limited information on the natural course of chronic ITP in children. We aimed to evaluate the clinical and demographic characteristics of children with chronic ITP in the era before the availability of eltrombopag. Methods: A total of 86 children with chronic ITP between 1978-2...
Saved in:
Main Authors: | Begum S. Koc (Author), Gul Nihal Ozdemir (Author), Javid Alakbarli (Author), Hilmi Apak (Author), Tiraje Celkan (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Spotlight on eltrombopag in the treatment of children with chronic immune thrombocytopenia
by: Lambert MP
Published: (2016) -
Eltrombopag use for refractory immune thrombocytopenia in pregnancy: A case report
by: Sarah J. Weingarten, et al.
Published: (2021) -
Cost-consequence model comparing eltrombopag and romiplostim in pediatric patients with chronic immune thrombocytopenia
by: Tremblay G, et al.
Published: (2018) -
Cost-per-responder analysis for eltrombopag and rituximab in the treatment of primary immune thrombocytopenia in Spain
by: Eduardo Anguita, et al.
Published: (2020) -
Cost-consequence model comparing eltrombopag versus romiplostim for adult patients with chronic immune thrombocytopenia
by: Tremblay G, et al.
Published: (2018)